Form 4 for TDOC Teladoc Health, Inc.
Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-27 · accession 0002036989-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-03 | 2026-02-27 | TDOC | Bliss Kelly | Pres, U.S. Group Health | M - OptEx | — | +51.3K | 68.4K | +301% | — |
| D | 2026-03-03 | 2026-03-02 | TDOC | Bliss Kelly | Pres, U.S. Group Health | S - Sale+OE | $5.12 | -26.6K | 84.7K | -24% | -$136.4K |
| DM | 2026-03-03 | 2026-02-27 | TDOC | Bliss Kelly | Pres, U.S. Group Health | M - OptEx | $0.00 | -51.3K | 0 | -100% | $0 |
| DM | 2026-03-03 | 2026-02-27+ | TDOC | Bliss Kelly | Pres, U.S. Group Health | A - Grant | $0.00 | +209.1K | 27.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-27 | M | A | 3,488 | — | 63,542 | D | — | — | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2026-03-02 | S | D | 26,647 | $5.12 | 84,747 | D | — | — | (F3) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| 3 | Common | Common Stock | 2026-02-27 | M | A | 5,198 | — | 111,394 | D | — | — | (F2) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 4 | Common | Common Stock | 2026-02-27 | M | A | 1,186 | — | 106,196 | D | — | — | (F2) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 5 | Common | Common Stock | 2026-02-27 | M | A | 36,610 | — | 105,010 | D | — | — | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 6 | Common | Common Stock | 2026-02-27 | M | A | 4,858 | — | 68,400 | D | — | — | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 7 | Derivative | Restricted Stock Units | 2026-02-27 | M | D | 4,858 | $0.00 | 19,435 | D | — · — to — | 4,858 Common Stock | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F5) On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. |
| 8 | Derivative | Restricted Stock Units | 2026-03-01 | A | A | 181,661 | $0.00 | 181,661 | D | — · — to — | 181,661 Common Stock | (F12) Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. (F13) One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 9 | Derivative | Performance Stock Units | 2026-02-27 | M | D | 5,198 | $0.00 | 22,260 | D | — · — to — | 5,198 Common Stock | (F2) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. (F11) On March 1, 2026, the reporting person earned 27,458 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 10 | Derivative | Restricted Stock Units | 2026-02-27 | M | D | 3,488 | $0.00 | 0 | D | — · — to — | 3,488 Common Stock | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F4) On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 11 | Derivative | Restricted Stock Units | 2026-02-27 | M | D | 36,610 | $0.00 | 73,222 | D | — · — to — | 36,610 Common Stock | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F6) On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 12 | Derivative | Performance Stock Units | 2026-02-27 | M | D | 1,186 | $0.00 | 0 | D | — · — to — | 1,186 Common Stock | (F2) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. (F7) On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 13 | Derivative | Performance Stock Units | 2026-02-27 | A | A | 27,458 | $0.00 | 27,458 | D | — · — to — | 27,458 Common Stock | (F9) Performance award amount determined based on metrics in respect of the issuer's 2025 financial results. (F8) Each performance stock unit represents a contingent right to receive one share of TDOC common stock. (F10) The performance stock units vest as to one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |